Perioperative Parameter and Treatment Outcomes of ECIRS in Asia
ConditionRenal Stone
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorChinese University of Hong Kong
About this trial
This is an observational, international, multicenter, cohort study, prospectively collecting clinical data registry on consecutive patients with urinary stone undergoing ECIRS.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with urinary calculi
Undergoing Endoscopic Combined Intrarenal Surgery (ECIRS)
Agreed to consent for the study
Disqualifiers
Patients who have ECIRS for other conditions, such as urothelial cancer etc.
Patients who intraoperative record was incomplete.
Patients only have either PCNL or ureteroscopy done (not both)
Trial population
Patients diagnosed with urinary stones and planned for ECIRS
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
ECIRS
Other interventionEndoscopic Combined Intrarenal Surgery
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Target Stone status
The fragmentation rate of target stone
Time frame
up to 1 year2
Treatment related complication
he 30-day complications will be graded according to the Clavien-Dindo classification
Time frame
Thirty days after the operationSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov